Theravance Biopharma
TBPH
TBPH
122 hedge funds and large institutions have $648M invested in Theravance Biopharma in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
2.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
46
Reduced
27
Closed
13
Calls
$9.48M
Puts
$4.19M
Net Calls
+$5.29M
Net Calls Change
+$5.24M
Top Buyers
| 1 |
WAM
1
Weiss Asset Management
Boston,
Massachusetts
|
$75.6M |
| 2 |
2
Two Sigma Advisers
New York
|
$7.06M |
| 3 |
3
Two Sigma Investments
New York
|
$6.62M |
| 4 |
4
Millennium Management
New York
|
$6.6M |
| 5 |
NM
5
Newtyn Management
New York
|
$25.3M |
